How is XBI doing right now?
In plain terms: XBI is 16.2% below its highest-ever price. Dipsern checks every past time it was this far down and grades how the next 90 days usually went.
XBI (SPDR S&P Biotech ETF) is 16.2% below its historical peak. Tape reads in a moderate correction, with the last trade at $145.04. A drawdown of this depth is where patient buyers start paying attention. Historically the asymmetry begins to favor accumulation here, especially when paired with structural demand.
